Association of Vitamin D level with clinical status in inflammatory bowel disease: A 5-year longitudinal study

American Journal of Gastroenterology

Volumn 111, Issue 5, 2016, Pages 712-719

  Kabbani, Toufic A ^a   Koutroubakis, Ioannis E ^a   Schoen, Robert E ^a   Ramos Rivers, Claudia ^a   Shah, Nilesh ^a   Swoger, Jason ^a   Regueiro, Miguel ^a   Barrie, Arthur ^a   Schwartz, Marc ^a   Hashash, Jana G ^a   Baidoo, Leonard ^a   Dunn, Michael A ^a   Binion, David G ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; GOLIMUMAB; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; NARCOTIC AGENT; PREDNISONE; VITAMIN D;

ABDOMINAL PAIN; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ACTIVITY SCORE; DISEASE COURSE; EMERGENCY WARD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY BOWEL DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VITAMIN D;

EID: 84960194082     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.53     Document Type: Article

References (29)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12 (Suppl 1 ): S3-S9
2. Froicu M, Weaver V, Wynn TA, et al. A crucial role for the vitamin D receptor in experimental Inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-92
3. Cantorna MT, Munsick C, Bemiss C, et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine Inflammatory bowel disease. J Nutr 2000; 130: 2648-52
4. Aranda R, Sydora BC, McAllister PL, et al. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol 1997; 158: 3464-73
5. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and Inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 125-36
6. Stio M, Martinesi M, Bruni S, et al. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of Inflammatory bowel disease patients. Int Immunopharmacol 2006; 6: 1083-92
7. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the Inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54
8. Loftus EV Jr, Sandborn WJ. Epidemiology of Inflammatory bowel disease. Gastroenterol Clin N Am 2002; 31: 1-20
9. Skaaby T, Husemoen LL, Thuesen BH, et al. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 2015; 50: 231-8
10. Loftus EV Jr. Clinical epidemiology of Inflammatory bowel disease: Incidence, prevalence, and environmental Influences. Gastroenterology 2004; 126: 1504-17
11. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn?s disease. Gastroenterology 2012; 142: 482-9
12. Holick MF. Vitamin D defi ciency. N Engl J Med 2007; 357: 266-81
13. WHO. A ges Standardization o f Rates: A New WHO Standard. Available at http://www.who.int/healthinfo/paper31.pdf; last accessed on 26 February 2016
14. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of Inflammatory bowel disease based on results from the Asia-pacifi c Crohn?s and colitis epidemiology study. Gastroenterology 2013; 145: 158-65
15. Vermeire S, Schreiber S, Sandborn WJ, et al. Correlation between the Crohn?s disease activity and Harvey-Bradshaw indices in assessing Crohn?s disease severity. Clin Gastroenterol Hepatol 2010; 8: 357-63
16. Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induces clinical and histologic remission in patients with refractory Inflammatory bowel disease. Ann Intern Med 1989; 110: 353-6
17. Jowett SL, Seal CJ, Barton JR, et al. The short Inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol 2001; 96: 2921-8
18. Ramos-Rivers C, Regueiro M, Vargas EJ, et al. Association between telephone activities and features of patients with Inflammatory bowel disease. Clin Gastroenterol Hepatol 2014; 12: 986-94
19. McCarthy D, Duggan P, O?Brien M, et al. Seasonality of vitamin D and bone turnover in patients with Crohn?s disease. Aliment Pharmacol Ther 2005; 21: 1073-83
20. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D defi ciency in patients with Inflammatory bowel disease: association with disease activity and quality of life. J Parenter Enteral Nutr 2011; 35: 308-16
21. de Bruyn JR, van Heeckeren R, Ponsioen CY, et al. Vitamin D defi ciency in Crohn?s disease and healthy controls: a prospective case-control study in the Netherlands. J Crohns Colitis 2014; 8: 1267-73
22. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn?s disease. Inflamm Bowel Dis 2013; 19: 1921-7
23. Blanck S, Aberra F. Vitamin d defi ciency is associated with ulcerative colitis disease activity. Dig Dis Sci 2013; 58: 1698-702
24. Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in Inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995; 10: 250-6
25. Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in Inflammatory bowel disease patients reveals a subset of Crohn?s disease patients wiThelevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 2004; 53: 1129-36
26. Lee SH, Kim HJ, Yang SK, et al. Decreased trabecular bone mineral density in newly diagnosed Inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol 2000; 15: 512-8
27. Fu YT, Chatur N, Cheong-Lee C, et al. Hypovitaminosis D in adults with Inflammatory bowel disease: potential role of ethnicity. Dig Dis Sci 2012; 57: 2144-8
28. Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn?s disease - A randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32: 377-83
29. Garg M, Rosella O, Lubel JS, et al. Association of circulating vitamin D concentrations with intestinal but not systemic Inflammation in Inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 2634-43